Joincare Pharmaceutical Group Industry Co (XSWX:JCARE) Moat Score: 0/10 (As of Aug. 13, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:JCARE Joincare Pharmaceutical Group Industry Co Ltd XSWX:JCARE
80 GF Score
Price $8.00
GF Value $9.20
! 3 Warning Signs
View Full Analysis

What is Joincare Pharmaceutical Group Industry Co Moat Score?

Joincare Pharmaceutical Group Industry Co has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Joincare Pharmaceutical Group Industry Co has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Joincare Pharmaceutical Group Industry Co might have No Moat - No discernible moat.


Joincare Pharmaceutical Group Industry Co  (XSWX:JCARE) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Joincare Pharmaceutical Group Industry Co Moat Score Related Terms

XSWX:JCARE
80GF Score
Joincare Pharmaceutical Group Industry Co Ltd XSWX:JCARE
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Joincare Pharmaceutical Group Industry Co (XSWX:JCARE) Overvalued in 2026?

Based on GuruFocus' analysis, Joincare Pharmaceutical Group Industry Co stock appears to be undervalued. The current stock price of $8.00 is trading 13% below its estimated GF Value™ of $9.20.

Key valuation signals for XSWX:JCARE:

  • Moat Score: 0
  • GF Value™: $9.20 vs. price of $8.00 (13% below fair value)
  • GF Score™: 80/100 with 3 warning signs

No single metric tells the full story. See the XSWX:JCARE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Joincare Pharmaceutical Group Industry Co Business Description

Other Exchanges 600380:China
Address No. 17, Langshan Road, North District, High-tech Zone, Nanshan District, Guangdong, Shenzhen, CHN, 518057
Joincare Pharmaceutical Group Industry Co Ltd is an integrated pharmaceutical company, the business scope covers healthcare products, APIs, final dosage forms, prescription drugs, OTCs, Chinese traditional medicine, chemical drugs, and testing agents. APIs are antibiotic series and their intermediates 7ACA, 4AA and F9. Prescription drugs focus on the realms of the digestive tract, a blood vessel of heart and brain, infection, tumor, nervous cerebrovascular section, urinary system etc. OTCs include gastrointestinal drug Dele-Livzon, Live Bifidobacterium Preparation, oral ulcer drugs Yiketie, cold medicine Antiviral Oral Granule, External use skin medicine.
80GF Score

Get the complete analysis for XSWX:JCARE

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.00
Price
$9.20
GF Value